- Original Article
- Open Access
Clinical characteristic and intraoperative findings of uterine perforation patients in using of intrauterine devices (IUDs)
Gynecological Surgery volume 15, Article number: 3 (2018)
Intrauterine devices (IUDs) are the most popular form of contraception used worldwide; however, IUD is not risk-free. IUD migrations, especially uterine perforations, were frequently occurred in patients. The aim of this study was to investigate the clinical characteristics and intraoperative findings in patients with migrated IUDs.
29 cases of uterine perforation associated with migrated IUDs and 69 control patients were followed between January 2008 to March 2015. Patients who used IUDs within first 6 months from the last delivery experienced a characteristically high rate of the perforation of the uterine wall. A significantly larger number of IUD insertion associated with uterine perforation were performed in rural hospitals or operated at a lower level health care system. There was no clear difference in the age and presented symptoms in patients between two groups. Majority of contraceptive intrauterine devices was the copper-releasing IUDs. Furthermore, patients who used V-shaped IUD showed significantly higher incidence of pelvic adhesions when compared with the users of O-shaped IUDs.
Unique clinical characteristics of IUD migration were identified in patients with uterine perforation. Hysteroscopy and/or laparoscopy were the effective approaches to remove the migrated IUDs. Improving operating skills is required at the lower level of health care system.
Intrauterine devices (IUDs) are the most popular form of contraception used by millions of women worldwide, particularly in developing countries . Currently, two major types of IUDs are used, the copper-releasing intrauterine device (IUD) and the levonorgestrel-releasing intrauterine system (LNG-IUS) [2, 3]. However, IUDs are not risk-free, and lots of complications have been reported, including expulsion, malpositioning, and uterine perforation . Among them, the majority were missing the IUDs, and most of the missing IUDs were found in the uterus ; however, the device would also pass through the uterine serosa causing uterine perforation. Uterine perforation is rare, but it may cause serious problems, including pain, abnormal bleeding, bowel or bladder perforation, and fistula formation, when IUDs migrate into the pelvic peritoneal space invading the adjacent organs. Thus far, the invasion of omentum, pouch of Douglas, the serosa of the ileum, the bladder, and the rectum has been reported in patients with uterine perforation [3, 5,6,7,8]. The rate of uterine perforation was 0.3–2.6 in every 1000 users of copper IUD insertion, and the respective rate for LNG-IUS insertion was 0.3–2.2 [9,10,11,12,13,14,15]. Uterine perforation can be primary (at the time of insertion) or secondary (4 weeks or more after the insertion took place). Lots of risk factors were proposed for uterine perforation, including immediate post-partum period [10, 16], breastfeeding [14, 17], extremes of uterine posture , intrauterine device shape not fitting well with uterine cavity , inexperience of the inserter, and inappropriate technique during the IUD insertion [15, 16, 20].
Specifically, the use of intrauterine devices has been changing in parallel with social-economic development of China. In the 1980s, 90% of all IUDs were stainless steel rings; they were cheaper than copper T-shaped IUDs but were also less effective and had a greater rate of expulsion . In the 1990s, the use switched to T-shaped copper IUDs, although a large population of women was still using the steel rings . Today, there are dozens of different types of IUDs available on the market that clearly mirror their clinical application [22,23,24]. Most of the IUDs used in China are manufactured in China, and the majority is the copper-releasing IUDs, including all types of T-shaped and V-shaped copper-releasing IUDs. Recently, some overseas products, as LNG-IUS  and GyneFix , have also been introduced to China.
Although lots of factors have been proposed, the precise cause of uterine perforation is not well understood . The risk factors associated with use of IUDs by Chinese women were not reported. In this retrospective study, we attempted to evaluate all potential risk factors for uterine perforation associated with the use of IUDs by Chinese women and provide suggestions possibly useful for the management of IUD migrations.
Patients enrolled and surgery management
Patients admitted to the 3rd Xiangya Hospital of Central South University (CSU) at Hunan, China, from January 2008 to March 2015 were reviewed for uterine perforation. Uterine abnormalities were evaluated by by B-scan ultrasonography (B-scan), X-rays, or computed tomography (CT). Two groups of patients with (1) uterine perforation and (2) non-uterine perforation were enrolled into the study. In the event of uterine perforation, the IUD devices passed through the uterus and caused uterine injury; 29 cases were included in this study. In the patients without uterine perforation (“non-uterine perforation”), there was a displacement of IUD, but the device was still located in the uterus; 69 cases were included in the study. Patients who had preexisting IUDs but could not find the missing IUDs, which might be due to expulsion, were excluded from the study. This study was approved by the Review Board and Ethics Committee of the 3rd Xiangya Hospital of Central South University (# 2008-S010). All patients signed a statement of consent to participate under the “ethics, consent, and permissions” heading and another informed consent to the publication of collected data.
In patients with non-uterine perforation, the IUDs were malpositioned in the uterine or embedded in the uterine myometrium but did not cause perforation of the organ. All these patients underwent hysteroscopy as initial step in removing the dislocated IUDs. Patients with uterine perforation had partially or completely perforated organ throughout the uterine serosa. In these patients, laparoscopy and/or hysteroscopy or cystoscopy were applied to remove the migrated IUDs. Since one patient showed perforated ileum; laparotomy was performed to repair the intestine after the removal of the IUD.
Patient information and intraoperative findings
Patient information, including age, medical history, history of previous pregnancy outcome, symptoms encountered by the patient, the time of IUD insertion after the last delivery, the time from the IUD insertion to diagnosis, and health facility where IUD insertion was conducted, was collected when the patients came to the hospital.
The intraoperative findings were recorded during the surgical operations, which include type and location of IUD, site of uterine perforation, surgical management, and pelvic adhesion. These and other associated complications were also recorded during hysteroscopy and/or laparoscopy, cystoscopy, and laparotomy.
Data analysis was performed using GraphPad Prism ver. 6 (GraphPad Software, La Jolla, CA). A nonparametric, the Mann-Whitney U test was used to assess the differences in parameters between the uterine perforation and non-uterine perforation groups, while Fisher’s exact test was applied in the evaluation of the incidence of these two groups.
Multiple factors contributed to uterine perforation occurrence
The patients’ characteristics were summarized in Table 1. The average age of all patients was 37, and there was no significant difference between the groups of patients (Mann-Whitney test, p > 0.05). The median age was 35 (range 22–60) for uterine perforation and 38 (range 20 to 71) for non-uterine perforation groups (Table 1).
In this study, we found 10 patients (34.5%) with the uterine perforation showing no signs or symptoms of a disease at hospital arrival screens. Thirty-two patients (46.4%) in the non-uterine perforation group did not have symptoms, either. While a large number of patients were encountered with different symptoms, most of them were presented as pelvic and/or abdominal pain. Ten patients (34.5%) in the uterine perforation group had pain, and 15 (21.7%) of those with pain were observed in the non-uterine perforation group. Pain prevalence was followed by menstrual disorders affecting 10.3% of patients in the uterine perforation and 17.4% of them in the group of non-uterine perforation.
Pregnancy occurred in 17.2% in the uterine perforation group and 5.8% of cases in the non-uterine perforation. About 13.8% of patients with uterine perforation were associated with IUD missing strings and 5.8% of those with non-uterine perforation. Three cases of vaginal bleeding were observed, all of them in the group of non-uterine perforation (Table 1).
The time interval between IUD insertion and the time of last delivery was shorter in the uterine perforation group when compared with the group of non-uterine perforation. A half of the patients (n = 15, 51.7%) with the uterine perforation inserted the device within 6 months after delivery, which is significantly higher than in the patients of the no uterine perforation group (n = 17, 24.6%;Table 1, Fisher’s exact test, * = p < 0.05). The time passed from the insertion of IUD to diagnosis of uterine perforation (duration of IUD placement) tended to be longer (14 months in average) when compared with 93 months for the conditions of non-uterine perforation (Table 1).
There are three major types of IUDs that were typically used: T- and V-shaped copper-releasing IUDs and O-shaped IUDs (O-shaped IUDs referred to as stainless steel single or double rings). Our findings showed that uterine perforation cannot be associated with a particular type of IUD (Table 1). However, 89.7% (n = 26) of patients with uterine perforations inserted IUDs in rural hospitals or at lower level health care systems, in comparison with 69.6% (n = 48) of those with no uterine perforation treated in the same setting Table 1).
Intraoperative findings were associated with uterine perforation
If the IUDs were going through the uterine serosa, or entirely outside the uterus, invading the organs in the pelvic abdominal cavity would make it difficult to remove devices. This invokes an increased risk for severe complications.
There was not a clear pattern of the organs affected by displaced and protruding IUDs through the uterine. Myometrium appeared on the top of the scattered pattern of organ injury (n = 6, 20.7%) and greater omentum (n = 6, 20.7%), followed by the sigmoid colon (n = 5, 17.2%) (Fig. 2), left sacrouterine ligament (n = 3, 10.3%), bladder (n = 3, 10.3%), pouch of Douglas (n = 2, 6.9%), and rectal serosa (n = 2, 6.9%). One patient (3.4%) had injured uterus isthmus and affected ileum was observed in the other one (3.4%; Table 2).
We identified five types of IUDs that were implanted (Fig. 1A (a–e). Most of them are T-shaped copper-containing device (n = 10, 34.5%) and V-shaped copper-containing device (n = 13, 44.8%), which showed a random invasion of the pelvic peritoneum. The O-shaped IUDs predominantly invaded the left sacrouterine ligament (3/4, 75%; Table 2).
Uterine perforation frequently causes pelvic adhesion as reported before , but it is still unknown whether any typical type of IUD that is made in China is associated with pelvic adhesion. In our study, we found that V-shaped copper-releasing IUDs (12/13, 92.3%) induced significantly higher rate of pelvic adhesion when compared with the O-shaped IUDs (1/4, 25%) (Fig. 1B (a), Fisher’s exact test, * = p < 0.05). The pain induction could not be related to any particular device evaluated in this study (Fig. 1B (b)).
Laparoscopy and/or hysteroscopy were applied to remove the migrated IUDs
Once the patients were diagnosed with uterine perforation and the device’s location was identified, they underwent surgical removal of migrated IUDs. Five patients (17.2%) out of 29 underwent laparoscopy for removal of the IUDs, while 22 patients (75.9%) underwent hysteroscopy along with laparoscopy (Table 3 and Fig. 2). Since one patient experienced ileum injury, it underwent laparotomy for exploration, IUD removal, and the wound repair. In the other patient, the IUD migrated into the bladder, and the device was removed by cystoscopy (Table 3). All the patients showed signs of healthy recovery during hospitalization and were discharged within 1 week.
Uterine perforation is a serious complication associated with IUD use. The precise mechanism of induction of uterine perforation is not well understood. A lot of risk factors were proposed for the induction of uterine perforation [10, 14, 15, 19]. In this study, we found that the time of IUD insertion after the last delivery is shorter in the uterine perforation group when compared with the subjects without uterine perforation. A sharp increase of the uterine perforation rate occurred in the subjects with IUD inserted up to 6 months after delivery. The incidence of uterine perforation within the first 6 months was significantly higher when compared with the subjects treated under the same conditions but without uterine perforation (Table 1, 51.7 vs. 24.6%, p < 0.05). At this stage, most patients were still in the breastfeeding period, and all 15 subjects in the lactation period were diagnosed with uterine perforation. This finding is consistent with previous reports that women in the lactation period are at a high risk of uterine perforation [14, 17]. In addition, most of the patients with the uterine perforation had received an IUD at rural hospitals or a lower level of health care systems. Typically, the experience and technique of an obstetrician-gynecologist in rural hospitals or lower level health care systems are poorer when compared to those in urban hospitals in China. Many obstetrician-gynecologists in rural hospital or a lower level of health care systems are lacking an efficient training on handling of IUD insertion, which may directly cause perforation at the insertion time. As it was reported before, IUD migrations at the time of insertion may directly contribute to uterine perforation [14, 17, 28].
The IUD use in China has a long history, and it can be found as earlier as 1979 ; however, the IUD devices were still not well managed. In the early years, most IUDs were steel rings (designated as O-shaped in this study) due to its low cost, and the devices were provided free of charge in some hospitals [1, 22]. Later, the copper-releasing IUDs replaced the steel rings as many problems were encountered by using the rings .Nowadays, copper-releasing IUDs have become the prevailing devices in clinical application in China [22, 24]. Recently, the levonorgestrel intrauterine system (LNG-IUS) along with other optimized IUDs were also provided to Chinese women . In this study, the majority of devices that induced uterine perforation were copper-releasing IUDs with T-shaped copper (n = 10) followed by V-shaped copper IUDs (n = 13) and four of those with O-shaped IUDs (Table 1). A larger number of patients is required to assess the risk factors associated with different types of IUDs, including the LNG-IUS that are used in China.
Pelvic adhesions as a consequence of uterine perforation also frequently occurred in the patients, but the mechanism is still unknown; it may due to different actions of the devices . In our study, we found that 12 out of the 13 patients with V-shaped contraceptive intrauterine devices had pelvic adhesions (Fig. 1B). This is significantly higher when compared with the patients that used O-shaped IUDs. The reason(s) for the higher rate of pelvic adhesions in patients who used V-shaped IUD is unknown at present. This issue requires a thorough investigation.
If the IUDs were missing, a method of searching for the strings or IUDs in the uterine cavity is sweeping by using uterine forceps. However, there are many IUDs used by Chinese women that do not have any string  (Fig. 1). The exploration success rate highly varies and is dependent on the experience and applied technique by the obstetrician-gynecologist who removes the IUDs using forceps or hooked instruments . Under these aggravating circumstances, hysteroscopy and/or laparoscopy are suggested procedures, which secure a very high success rate [6,7,8, 31]. If the IUDs migrated into the pelvic peritoneal cavity, the procedures become dubious. Currently, the WHO recommends that all misplaced IUDs should be surgically removed once they are identified . Some researches, however, suggest that if the migrated IUDs do not cause serious complications or significant symptoms, their removal is not necessary [33, 34]. In our study, all displaced IUDs associated with uterine perforation were successfully removed using laparoscopy and/or hysteroscopy that was accompanied with significant complications. Laparoscopy and/or hysteroscopy provide a high success rate in the removal of migrated IUDs in the patients with uterine perforation.
Potential risk factors associated with IUD use for the uterine perforation in Chinese population of patients are identified in a retrospective observational study. Hysteroscopy and/or laparoscopy are effective approaches in removing of displaced IUDs. A tailored training program planned to meet patients’ needs in rural areas and at a lower level of health care system may be justified.
d'Arcangues C (2007) Worldwide use of intrauterine devices for contraception. Contraception 75(6 Suppl):S2–S7
Marchi NM, Castro S, Hidalgo MM, Hidalgo C, Monteiro-Dantas C, Villarroeal M et al (2012) Management of missing strings in users of intrauterine contraceptives. Contraception 86(4):354–358
Kaislasuo J, Suhonen S, Gissler M, Lahteenmaki P, Heikinheimo O (2013) Uterine perforation caused by intrauterine devices: clinical course and treatment. Hum Reprod 28(6):1546–1551
Boortz HE, Margolis DJ, Ragavendra N, Patel MK, Kadell BM (2012) Migration of intrauterine devices: radiologic findings and implications for patient care. Radiographics 32(2):335–352
Rahnemai-Azar AA, Apfel T, Naghshizadian R, Cosgrove JM, Farkas DT (2014) Laparoscopic removal of migrated intrauterine device embedded in intestine. JSLS 18(3):e2014.00122.1-5
Kho KA, Chamsy DJ (2014) Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes. J Minim Invasive Gynecol 21(4):596–601
Agacayak E, Tunc SY, Icen MS, Oguz A, Ozler A, Turgut A et al (2015) Evaluation of predisposing factors, diagnostic and treatment methods in patients with translocation of intrauterine devices. J Obstet Gynaecol Res 41(5):735–741
Mosley FR, Shahi N, Kurer MA (2012) Elective surgical removal of migrated intrauterine contraceptive devices from within the peritoneal cavity: a comparison between open and laparoscopic removal. JSLS 16(2):236–241
Heinemann K, Reed S, Moehner S, Minh TD (2015) Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on intrauterine devices. Contraception 91(4):274–279
Caliskan E, Ozturk N, Dilbaz BO, Dilbaz S (2003) Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 8(3):150–155
Harrison-Woolrych M, Ashton J, Coulter D (2003) Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? Contraception 67(1):53–56
Harrison-Woolrych M, Zhou L, Coulter D (2003) Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand. N Z Med J 116(1179):U538
Kaislasuo J, Suhonen S, Gissler M, Lahteenmaki P, Heikinheimo O (2012) Intrauterine contraception: incidence and factors associated with uterine perforation—a population-based study. Hum Reprod 27(9):2658–2663
Van Houdenhoven K, van Kaam KJ, van Grootheest AC, Salemans TH, Dunselman GA (2006) Uterine perforation in women using a levonorgestrel-releasing intrauterine system. Contraception 73(3):257–260
Zhou L, Harrison-Woolrych M, Coulter DM (2003) Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf 12(5):371–377
Andersson K, Ryde-Blomqvist E, Lindell K, Odlind V, Milsom I (1998) Perforations with intrauterine devices. Report from a Swedish survey. Contraception 57(4):251–255
Heartwell SF, Schlesselman S (1983) Risk of uterine perforation among users of intrauterine devices. Obstet Gynecol 61(1):31–36
Zakin D, Stern WZ, Rosenblatt R (1981) Complete and partial uterine perforation and embedding following insertion of intrauterine devices. I. Classification, complications, mechanism, incidence, and missing string. Obstet Gynecol Surv 36(7):335–353
Wildemeersch D, Hasskamp T, Goldstuck N (2015) Intrauterine devices that do not fit well cause side effects, become embedded, or are expelled and can even perforate the uterine wall. J Minim Invasive Gynecol 22(2):309–310
Harrison-Woolrych M, Ashton J, Coulter D (2002) Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women. Contraception 66(6):387–391
Li Yong Ping KLB, Rowe PJ, De Wei Z, Xian WS, Yin ZH, Wu Z (1994) The demographic impact of conversion from steel to copper IUDs in China. Int Fam Plan Perspect 20(4):124–130
Cheung VY (2010) Sonographic appearances of Chinese intrauterine devices. J Ultrasound Med 29(7):1093–1101
Cheung VY (2010) A 10-year experience in removing Chinese intrauterine devices. Int J Gynaecol Obstet 109(3):219–222
Zhang S, Li Y, Yu P, Chen T, Zhou W, Zhang W et al (2015) In vitro release of cupric ion from intrauterine devices: influence of frame, shape, copper surface area and indomethacin. Biomed Microdevices 17(1):19
Zhao S, Deng J, Wang Y, Bi S, Wang X, Qin W et al (2014) Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey. Patient Prefer Adherence 8:1449–1455
Cao X, Zhang W, Gao G, Van Kets H, Wildemeersch D (2000) Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic. Eur J Contracept Reprod Health Care 5(2):135–140
Goldstuck ND, Wildemeersch D (2014) Role of uterine forces in intrauterine device embedment, perforation, and expulsion. Int J Womens Health 6:735–744
Goldstuck ND, Holloway G (1988) IUD insertion forces: effects of recent childbirth and lactation. Adv Contracept 4(2):159–164
Bilian X (2007) Chinese experience with intrauterine devices. Contraception 75(6 Suppl):S31–S34
Su S, Zhao Z, Feng S, Dong B (2012) A novel medical device for removal of intrauterine devices under direct vision. Contraception 86(5):583–586
Balci O, Mahmoud AS, Capar M, Colakoglu MC (2010) Diagnosis and management of intra-abdominal, mislocated intrauterine devices. Arch Gynecol Obstet 281(6):1019–1022
World Health Organization (1987) Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 753:1-91
Markovitch O, Klein Z, Gidoni Y, Holzinger M, Beyth Y (2002) Extrauterine mislocated IUD: is surgical removal mandatory? Contraception 66(2):105–108
Adoni A, Ben CA (1991 Jan) The management of intrauterine devices following uterine perforation. Contraception 43(1):77–81
The authors thank all the members in the Department of Obstetrics and Gynecology, the 3rd Xiangya Hospital of Central South University, for their helpful assistance during the data collection.
Ethics approval and consent to participate
This study was approved by the Review Board and Ethics Committee of the 3rd Xiangya Hospital of Central South University.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Sun, X., Xue, M., Deng, X. et al. Clinical characteristic and intraoperative findings of uterine perforation patients in using of intrauterine devices (IUDs). Gynecol Surg 15, 3 (2018). https://doi.org/10.1186/s10397-017-1032-2
- Uterine perforation